Latest Insider Transactions at Io Biotech, Inc. (IOBT)
This section provides a real-time view of insider transactions for Io Biotech, Inc. (IOBT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of IO Biotech, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of IO Biotech, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 26
2024
|
Novo Holdings |
SELL
Open market or private sale
|
Direct |
23,478
-0.54%
|
$23,478
$1.31 P/Share
|
|
Jul 25
2024
|
Novo Holdings |
SELL
Open market or private sale
|
Direct |
51,522
-1.16%
|
$51,522
$1.33 P/Share
|
|
May 10
2024
|
Novo Holdings |
SELL
Open market or private sale
|
Direct |
658,809
-12.95%
|
$658,809
$1.22 P/Share
|
|
Feb 09
2024
|
Novo Holdings |
SELL
Open market or private sale
|
Direct |
658,809
-11.46%
|
$658,809
$1.5 P/Share
|
|
Nov 22
2023
|
Brian Burkavage Chief Accounting Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+30.3%
|
$5,000
$1.03 P/Share
|
|
Nov 21
2023
|
Brian Burkavage Chief Accounting Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+43.48%
|
$0
$0.99 P/Share
|
|
Aug 09
2023
|
Christian E Elling |
BUY
Grant, award, or other acquisition
|
Indirect |
7,901,234
+36.16%
|
$7,901,234
$1.9 P/Share
|
|
Aug 09
2023
|
Invest A/S Lundbeckfond |
BUY
Grant, award, or other acquisition
|
Direct |
7,901,234
+36.16%
|
$7,901,234
$1.9 P/Share
|
|
Aug 09
2023
|
Novo Holdings |
BUY
Open market or private purchase
|
Direct |
2,469,135
+30.2%
|
$4,938,270
$2.02 P/Share
|
|
Aug 09
2023
|
Vivo Capital Ix, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,157,894
+50.0%
|
$3,157,894
$1.9 P/Share
|
|
Aug 09
2023
|
Amy Sullivan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,382
+39.9%
|
$49,382
$1.9 P/Share
|
|
Aug 09
2023
|
Mai Britt Zocca Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,037
+49.76%
|
$37,037
$1.9 P/Share
|
|
Aug 09
2023
|
Devin Whittemore Smith General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4,938
+50.0%
|
$4,938
$1.9 P/Share
|
|
Mar 17
2023
|
Amy Sullivan Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
25,000
+50.0%
|
$50,000
$2.32 P/Share
|
|
Nov 09
2021
|
Jack Nielsen |
BUY
Open market or private purchase
|
Indirect |
650,000
+17.73%
|
$9,100,000
$14.0 P/Share
|
|
Nov 09
2021
|
Jack Nielsen |
BUY
Conversion of derivative security
|
Indirect |
2,365,545
+50.0%
|
-
|
|
Nov 09
2021
|
Invest A/S Lundbeckfond |
BUY
Open market or private purchase
|
Direct |
2,142,857
+26.16%
|
$29,999,998
$14.0 P/Share
|
|
Nov 09
2021
|
Invest A/S Lundbeckfond |
BUY
Conversion of derivative security
|
Direct |
3,906,595
+41.32%
|
-
|
|
Nov 09
2021
|
Mai Britt Zocca Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
26,580
+50.0%
|
-
|
|
Nov 09
2021
|
Claus A. Andersson |
BUY
Open market or private purchase
|
Indirect |
75,000
+4.02%
|
$1,050,000
$14.0 P/Share
|
|
Nov 09
2021
|
Claus A. Andersson |
BUY
Conversion of derivative security
|
Indirect |
1,716,490
+33.57%
|
-
|
|
Nov 09
2021
|
Vivo Capital Ix, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
650,000
+17.73%
|
$9,100,000
$14.0 P/Share
|
|
Nov 09
2021
|
Vivo Capital Ix, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,365,545
+50.0%
|
-
|
|
Nov 09
2021
|
Vanessa Malier |
BUY
Open market or private purchase
|
Indirect |
325,000
+20.95%
|
$4,550,000
$14.0 P/Share
|
|
Nov 09
2021
|
Vanessa Malier |
BUY
Conversion of derivative security
|
Indirect |
1,064,036
+50.0%
|
-
|
|
Nov 09
2021
|
Hbm Healthcare Investments (Cayman) Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
325,000
+10.78%
|
$4,550,000
$14.0 P/Share
|
|
Nov 09
2021
|
Hbm Healthcare Investments (Cayman) Ltd. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,365,545
+50.0%
|
-
|
|
Nov 09
2021
|
Novo Holdings |
BUY
Open market or private purchase
|
Direct |
325,000
+9.02%
|
$4,550,000
$14.0 P/Share
|
|
Nov 09
2021
|
Novo Holdings |
BUY
Conversion of derivative security
|
Direct |
2,952,932
+50.0%
|
-
|